Branded European Medicines

Branded European Medicines - During the first few years a new medicine becomes available, it is usually marketed as a brand under a name given by the pharmaceutical company that developed it. Companies take out patents (exclusive rights) on each new drug they discover to ensure they regain the money they spent on its development – which can be as much as £1 billion – and make a profit. Having a patent means only that company can produce the medicine for a certain length of time. During the remaining years, only that company can produce and sell the medicine to recover their costs and make a profit.

Choose Country For Brands